Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 447
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: Edmonton, Vancouver, Vancouver WA, Salem OR, Eugene OR,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Get alerts for new trials in your area by subscribing now
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Edmonton, Calgary, Great Falls MT, Vancouver,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Edmonton, Spokane WA, Abbotsford British Columbia,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Edmonton, Tacoma WA, Denver CO, Scottsdale AZ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase3, Recruiting
Evaluation of Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
for
Opioid-use Disorder
Location: Edmonton, Calgary, Vancouver
Sponsor: University of British Columbia
Sex: All
Age: 18+
Code: NCT04893525
Phase2, Phase3, Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
for
Acute Respiratory Distress Syndrome, Infections
Location: Edmonton, Calgary, North Vancouver, Rochester MN,
Sponsor: BioAegis Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT05947955
Phase2, Recruiting
A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress
for
Mild Respiratory Distress
Location: Edmonton, Montreal
Sponsor: NuvOx LLC
Sex: All
Age: 18+
Code: NCT06658535
Phase1, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Edmonton, Kamloops, Abbotsford British Columbia,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Sherwood Park, Calgary, Regina, Missoula MT,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sherwood Park, Calgary, Kelowna, Spokane WA,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
for
Post-mastectomy Pain Syndrome, Breast Cancer,
Location: Edmonton, Calgary, Thunder Bay, Toronto, North York,
Sponsor: University Health Network, Toronto
Sex: All
Age: 18 - 70+
Code: NCT04874038
Phase3, Recruiting
Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)
for
Wrist Arthritis, Wrist Arthropathy,
Location: St. Albert, Calgary, Saskatoon, London, Ottawa